Worth Asset Management LLC Purchases Shares of 4,265 SPDR S&P Biotech ETF $XBI

Worth Asset Management LLC acquired a new position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 4,265 shares of the exchange traded fund’s stock, valued at approximately $427,000.

A number of other hedge funds and other institutional investors have also made changes to their positions in the business. AdvisorNet Financial Inc increased its stake in SPDR S&P Biotech ETF by 7.3% in the third quarter. AdvisorNet Financial Inc now owns 1,463 shares of the exchange traded fund’s stock valued at $147,000 after purchasing an additional 100 shares during the last quarter. Investment Partners Asset Management Inc. grew its holdings in SPDR S&P Biotech ETF by 4.0% in the 2nd quarter. Investment Partners Asset Management Inc. now owns 3,257 shares of the exchange traded fund’s stock valued at $270,000 after buying an additional 125 shares during the period. Compass Ion Advisors LLC increased its stake in shares of SPDR S&P Biotech ETF by 3.9% during the 2nd quarter. Compass Ion Advisors LLC now owns 3,727 shares of the exchange traded fund’s stock valued at $309,000 after acquiring an additional 140 shares during the last quarter. CWC Advisors LLC. increased its stake in shares of SPDR S&P Biotech ETF by 2.8% during the 3rd quarter. CWC Advisors LLC. now owns 5,707 shares of the exchange traded fund’s stock valued at $572,000 after acquiring an additional 157 shares during the last quarter. Finally, McAdam LLC lifted its holdings in shares of SPDR S&P Biotech ETF by 5.1% during the 2nd quarter. McAdam LLC now owns 3,273 shares of the exchange traded fund’s stock worth $271,000 after acquiring an additional 159 shares during the period.

SPDR S&P Biotech ETF Stock Performance

SPDR S&P Biotech ETF stock opened at $124.98 on Friday. SPDR S&P Biotech ETF has a 1 year low of $66.66 and a 1 year high of $126.50. The firm has a 50 day moving average price of $117.08 and a 200 day moving average price of $100.17. The company has a market cap of $7.59 billion, a price-to-earnings ratio of 11.47 and a beta of 0.93.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.